Workshop and Seminars

• Evening Seminar, Discussion and Dinner: Tuesday 19th June 2012

Practical Strategies for Adapting Cell-Based Assays to High-Content Screening Platforms

Registration 18:15 • Start 18:30 • Dinner 20:30

This interactive evening seminar will discuss the best practices for adapting cell-based assays for use in high-content screening platforms. Some of the issues being addressed will include:
• Cell-based assay development and preparation for use in high-content screening
• Assay miniaturisation
• Adapting from high-throughput to high-content screening
• Overview of technical / instrumentation solutions available: How to identify the right provider for your research needs
• Image acquisition for high-content screening assays
• Interactive discussion and case study examples of success assay development

Seminar Leader: Anthony Davies, Head of Irish National Centre for High-Content Analysis and Screening, Trinity College Dublin, Republic of Ireland

• Post-Conference Workshop, Thursday 21 March 2012

Practical Strategies for Developing and Screening with Complex 3D Cell Culture Assays

Registration 09:30 • Start 10:00 • End 16:00

Lunch, morning and afternoon refreshements and documentation will be provided

This full day workshop will focus on overcoming the practical challenges of designing and screening with complex 3D cell culture assays in high throughput and high content screening platforms. Through a series of case studies and practical discussions, some of the topics to be addressed include:
• Practical considerations for the development of 3D assays for HTS or HCS
• Transitioning from 2D to 3D assays
• Optimising co-cultures for 3D assays
• 3D matrix material considerations
• Comparison between 2D and 3D assays and transfer to in vivo development
• Benefits of 3D assays in drug discovery
• 3D data analysis
• Case studies of application of 3D cell culture assays in screening campaigns

Workshop Leaders to Include:
Christelle Perrault, Kinases & Phenotypic Screenings, Sanofi Aventis, France
Olivier Pardo, Team Leader, Lecturer, Imperial College London, UK
Albin Rudisch, Lead Discovery, Boehringer-Ingelheim, Austria